Nexa3D, a leading US manufacturer of high-performance 3D printers for industrial applications, and Addifab, a pioneer in 3D printed injection mould tooling, have announced a partnership to bring a novel 3D printed injection mould tooling platform to injection moulders worldwide.
“Injection moulding is a complex process, and the tool building is the most complex part of the process. With Freeform Injection Moulding, we provide injection moulders with a fully transparent set of tools (no pun intended) that will allow them to fast-track tool designs and validations while raising the bar on tool innovation. Now we can take these capabilities to the next level by partnering with Nexa3D to broaden access and superpower performance.”– Lasse Staal, co-founding CEO of Addifab
3D Printed Injection Mould Tooling Platform
Nexa3D and AddiFab have joined hands to sustainablydigitise injection moulding. They are following through with this by bringing a 3D printed injection mould tooling platform into mainstream. The platform, Freeform Injection Moulding (FIM), offers a compelling value proposition: The FIM process, which is based on 3D printing technology, allows users to additively manufacture complex injection mould tooling in hours rather than weeks or months. Most thermoplastic materials, including reinforced high-performance feedstocks, are compatible with these tools. They can also be dissolved, allowing for the moulding of complex components that would be difficult – if not impossible – to mould with traditional metal tooling.
Nexa3D will supply users of Freeform Injection Moulding with their NXE 400 system, which includes the industrial 3D printer as well as wash and cure units, while Addifab will provide proprietary tooling resins and post-processing equipment.
Through this collaboration, Nexa3D will supply their NXE 400 system – including the industrial 3D printer as well as wash and cure units – to users of Freeform Injection Moulding, while Addifab will be supplying their proprietary tooling resins and post-processing equipment.
“I had the opportunity to witness the powerful impact of Freeform Injection Moulding (FIM) for the first time at the RAPID + TCT conference in 2019, and was instinctively intrigued by its potential to reimagine additive tooling. As both Addifab and Nexa3D have since productized and industrialized our respective processes, it became obvious that together, we can achieve much more by digitizing injection moulding at convincing scale sustainably. I can’t wait to see the far-reaching impact of our collaboration.”– Avi Reichental, Co-Founder, Chairman, and CEO of Nexa3D
Nexa3D and Addifab will present their joint solution at the RAPID + TCT show in Detroit from the 17th to the 19th of May 2022. In Palo Alto, California, the companies are also establishing joint Silicon Valley demo facilities. Carsten Jarfelt, Addifab US Chief Commercial Officer, will be heading the demo office
The3D printed injection mould tooling platform or the Freeform Injection Moulding, powered by the NXE 400 systems, is available immediately.
About Addifab: Addifab is transforming the injection moulding industry based on one-to-one market knowledge and second-to-none ambitions. Backed by years of experience, we have developed a unique soluble mould tooling technology enabling Freeform Injection Moulding.
About Manufactur3D Magazine: Manufactur3D is an online magazine on 3D Printing. Visit our Tech News page for more updates on Global 3D Printing News. To stay up-to-date about the latest happenings in the 3D printing world, like us on Facebook or follow us on LinkedIn and Twitter.